Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CGONthis companyCG Oncology Inc.	$75.59	-19.96×	4.26×	794.47×	-19.96×	-105.2%	-15.0%	-4722.1%	-3985.0%	-21.4%	-25.0%	-4.1%	0.01×	0.16×	0×	24.63×	0.0%	3	58.05	1	C-
IBRXImmunityBio, Inc.	$7.01	-5.21×	-3.65×	16.08×	-11.68×	-355.9%	99.3%	-226.0%	-310.2%	70.3%	-56.9%	-17.0%	-1.76×	-3.53×	-2.28×	5.1×	0.0%	3	-10.89	2	C
URGNUroGen Pharma Ltd.	$25.76	-7.34×	-10.68×	10.26×	-8.44×	-186.4%	88.7%	-113.7%	-139.8%	145.5%	-81.1%	-14.4%	-1.22×	-0.13×	-3.69×	4.01×	0.0%	2	-2.29	2	C
Peer median	—	-6.28×	-7.16×	13.17×	-10.06×	-271.2%	94.0%	-169.9%	-225.0%	107.9%	-69.0%	-15.7%	-1.49×	-1.83×	-2.98×	4.55×	0.0%	3	-6.59	2	—